Allworth Financial’s Meridian Bioscience Inc VIVO Stock Holding History

Allworth Financial’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12	Closed	-$410	–	3350
2022 Q4	$410	Hold	12	–	–	﹤0.01%	2683
2022 Q3	$0	Hold	12	–	–	﹤0.01%	3244
2022 Q2	$0	Hold	12	–	–	﹤0.01%	2958
2022 Q1	$0	Buy	+12	New	+$285	﹤0.01%	2465
2021 Q2	–	Sell	-300	Closed	-$8K	–	1700
2021 Q1	$8K	Buy	+300	New	+$7.13K	﹤0.01%	1047

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Allworth Financial's VIVO Position: Q1 2023 in Review

Allworth Financial sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 12 shares — an estimated $410 sold.

Allworth Financial first reported a position in VIVO in Q1 2021 and held it in 5 quarters. The position peaked at $8K in Q1 2021. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Allworth Financial reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Allworth Financial sold 12 Meridian Bioscience Inc shares in Q1 2023, an estimated $410.
Allworth Financial first reported a position in Meridian Bioscience Inc in Q1 2021 and held it in 5 quarters.
Allworth Financial's Meridian Bioscience Inc position peaked at $8K in Q1 2021.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Allworth Financial's 13F filing for Q1 2023, filed 18 Apr 2023.